Some 30,800 people reserved slots to get the Chinese-made Sinovac Biotech shot and 113,200 others booked doses of Pfizer-BioNTech's vaccine at community vaccine centers in the 24 hours ending at 8 p.m. Tuesday, the government said. The number of bookings soared from just 18,600 the day earlier.
Data was not available from private clinics, some of which are also offering Sinovac's shot.
Before the expansion, only some 200,000 people -- comprising just 5.4% of priority groups eligible like the elderly and healthcare workers -- had come forward for shots since the vaccine drive started on Feb. 26.
The total number of people able to access vaccines now represents some 70% of the city's population of 7.5 million, with adults aged 30 to 59 years old now eligible. The government added 23,000 new reservation slots to daily capacity on Tuesday, and has increased the number of community centers offering the BioNTech shot from seven to 19.
The extended drive comes as the city grapples with a new outbreak of the virus centered on its expatriate community, including employees of international financial firms. HSBC Holdings's main Hong Kong office was ordered to close until further notice after three people working in the building tested positive for covid-19.
Chief Executive Carrie Lam said at a Wednesday Legislative Council meeting that the government would explore whether there was room for virus-related social distancing measures to be relaxed for people who were vaccinated. She added that authorities had held preliminary talks with China regarding the easing of some travel restrictions for individuals who had received two vaccine doses.
While Hong Kong's healthy adult population is one of the first in the world to gain eligibility for inoculation, the expanded access reflects a major vaccine hesitation problem that will likely delay the city's ability to reopen to the world. Officials widened eligibility earlier than expected after uptake was dismal among priority groups, leaving millions of doses unused.
Demand for covid-19 vaccines has generally been lower in Asia, where contained outbreaks and low death tolls in places like Japan and Singapore has meant that people feel less urgency and more skepticism toward rapidly-developed shots.
It's unclear if the younger adult population will ultimately help boost these underwhelming numbers, after the initial burst of pent-up demand. An informal poll of 13 people in the 30 to 59 years old group on Tuesday showed that half were planning to get a vaccine now that they can.
George Lin, chief financial officer at Hua Medicine and a former banker at Bank of America, said he was so excited to book a slot that he had a sleepless night. He signed up early Tuesday morning and will receive his first dose of BioNTech's shot on Saturday in Causeway Bay.
"The first thing I would like to do is to travel internationally," Lin said, including to the U.S to see his two daughters. "If I were in the U.S., I would not get this until May."
Others said they did not want to take the risk. Resistance among Hong Kong residents has grown after reports of several deaths among inoculated people, though experts said none of them are directly tied to the vaccine.
"I don't trust the vaccines, there's not enough data to show it is safe, there's not been enough testing," said hairstylist Kei Ma, 41. "I don't know how many other things the government is hiding."
Political turmoil and China's tightening grip over the former British colony are complicating factors as city officials try to persuade people to take the vaccine. Lam received Sinovac's shot on Feb. 22 along with other cabinet members.
"The absence of trust only complicates the vaccine rollout," said Nicholas Thomas, associate professor in health security at City University of Hong Kong. "Short of mandatory vaccinations, which would likely be resisted by the population, the Hong Kong government is facing a slower path to reopening than its earlier successes against the virus suggested would be the case."
China is planning to ease requirements for foreigners applying for mainland visas from Hong Kong if they've received a Chinese vaccine, something that reassures David Bonnet, managing partner at real estate and hospitality advisory firm Delta State Holdings Ltd. who signed up for a Sinovac shot.
"If you live in Hong Kong and Macau, getting one of the Chinese vaccines probably will give some tangible benefits," he said. "I don't want to be subject to quarantines and I hope it will be easier to travel with Chinese vaccines. My hope is to resume business as normal."
Published : March 18, 2021
By : Syndication Washington Post, Bloomberg · Jinshan Hong